Prem Watsa - Fairfax Financial Holdings Ltd
Holding/activity history for Xeris Biopharma Holdings Inc (XERS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2024 Q4 | 139,687 | 0.03 | Reduce 18.28% | <0.01 | $3.38 | $472,142 | SEC |
| 2024 Q3 | 170,937 | 0.04 | $2.84 | $485,461 | SEC | ||
| 2024 Q2 | 170,937 | 0.03 | Add 12.91% | <0.01 | $2.24 | $382,899 | SEC |
| 2024 Q1 | 151,395 | 0.03 | $2.20 | $333,069 | SEC | ||
| 2023 Q4 | 151,395 | 0.02 | $2.35 | $355,778 | SEC | ||
| 2023 Q3 | 151,395 | 0.02 | $1.86 | $281,595 | SEC | ||
| 2023 Q2 | 151,395 | 0.03 | $2.61 | $395,141 | SEC | ||
| 2023 Q1 | 151,395 | 0.02 | $1.62 | $245,260 | SEC | ||
| 2022 Q4 | 151,395 | 0.01 | $1.32 | $199,841 | SEC | ||
| 2022 Q3 | 151,395 | 0.01 | $1.56 | $236,000 | SEC | ||
| 2022 Q2 | 151,395 | 0.01 | $1.53 | $232,000 | SEC | ||
| 2022 Q1 | 151,395 | 0.01 | $2.56 | $388,000 | SEC | ||
| 2021 Q4 | 151,395 | 0.01 | Buy | 0.01 | $2.91 | $441,000 | SEC |